Clinical Trials

Congenital heart disease

• ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood
  October 12, 2023
  Conditions: Congenital Heart Disease Interventions: Device: method comparison Sponsors: Radiometer Medical ApS Recruiting
• ALTERRA Post-Approval Study
  May 18, 2022
  Conditions: Pulmonary Valve Insufficiency; Complex Congenital Heart Defect; Tetralogy of Fallot; Pulmonary Regurgitation; RVOT Anomaly Interventions: Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System Sponsors: Edwards Lifesciences Recruiting
• Harmony TPV Post-Approval Study
  October 14, 2021
  Conditions: Congenital Heart Disease; Tetrology of Fallot; RVOT Anomaly; Pulmonary Regurgitation Interventions: Device: Harmony TPV System Sponsors: Medtronic Cardiovascular Recruiting
• COMPASSION S3 Post-Approval Study
  April 27, 2021
  Conditions: Complex Congenital Heart Defect; Dysfunctional RVOT Conduit; Pulmonary Valve Insufficiency; Pulmonary Valve Degeneration; Pulmonary Valve; Obstruction Interventions: Device: SAPIEN 3 THV Sponsors: Edwards Lifesciences Recruiting
• STeroids to REduce Systemic Inflammation After Infant Heart Surgery
  July 25, 2017
  Conditions: Congenital Heart Disease in Children; Inflammatory Response Interventions: Drug: Methylprednisolone; Drug: Isotonic saline Sponsors: Kevin Hill; National Center for Advancing Translational Sciences (NCATS) Completed
• ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
  April 26, 2017
  Conditions: Pulmonary Disease; Transcatheter Pulmonary Valve Replacement (TPVR); Tetralogy of Fallot; Congenital Heart Disease; Pulmonary Regurgitation Interventions: Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV Sponsors: Edwards Lifesciences Active, not recruiting
• National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
  August 2, 2016
  Conditions: Hypoplastic Left Heart Syndrome (HLHS) Interventions: Other: Collaborative Learning Network Sponsors: Children's Hospital Medical Center, Cincinnati Recruiting
• COMPASSION S3 – Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
  April 20, 2016
  Conditions: Complex Congenital Heart Defect; Dysfunctional RVOT Conduit; Pulmonary Valve Insufficiency; Pulmonary Valve Degeneration Interventions: Device: SAPIEN 3/SAPIEN 3 Ultra RESILIA THV; Device: SAPIEN 3 THV; Device: SAPIEN 3 Ultra RESILIA THV Sponsors: Edwards Lifesciences Recruiting